Insider · CIK 0001376547

Elizondo David R

Reports to the SEC for 1 company · CHAMPLIN, MN

sec.gov

Transactions

Companies

Filings

CIK

0001376547

Forms 4 and 5

Insider transactions

37 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2010-08-12	ATS MEDICAL INCD Disposition to Issuer	VP-Research & Development	DDisposition to Issuer	−110K sh	—	—	0
2010-08-12	ATS MEDICAL INCRestricted Stock UnitsD Disposition to Issuer	VP-Research & Development	DDisposition to Issuer	−20K sh	$4.00	−$80K	0
2010-08-12	ATS MEDICAL INCRestricted Stock UnitsD Disposition to Issuer	VP-Research & Development	DDisposition to Issuer	−17.7K sh	$4.00	−$70.7K	0
2010-08-12	ATS MEDICAL INCRestricted Stock UnitsD Disposition to Issuer	VP-Research & Development	DDisposition to Issuer	−52.6K sh	$4.00	−$210K	0
2010-08-12	ATS MEDICAL INCRestricted Stock UnitsD Disposition to Issuer	VP-Research & Development	DDisposition to Issuer	−52.9K sh	$4.00	−$211K	0
2010-08-12	ATS MEDICAL INCRestricted Stock UnitsD Disposition to Issuer	VP-Research & Development	DDisposition to Issuer	−53.4K sh	$4.00	−$214K	0
2010-08-12	ATS MEDICAL INCRestricted Stock UnitsD Disposition to Issuer	VP-Research & Development	DDisposition to Issuer	−15K sh	$4.00	−$60K	0
2010-06-30	ATS MEDICAL INCM Exercise/Conversion	VP-Research & Development	MExercise/Conversion	+40K sh	—	—	123,426.709
2010-06-30	ATS MEDICAL INCS Sale	VP-Research & Development	SSale	−13.1K sh	$3.96	−$52K	110,301.709
2010-06-30	ATS MEDICAL INCRestricted Stock UnitsM Exercise/Conversion	VP-Research & Development	MExercise/Conversion	−40K sh	—	—	0
2010-03-16	ATS MEDICAL INCS Sale	VP-Research & Development	SSale	−14.8K sh	$2.51	−$37K	82,953.075
2010-03-15	ATS MEDICAL INCM Exercise/Conversion	VP-Research & Development	MExercise/Conversion	+39.6K sh	—	—	97,713.075
2010-03-15	ATS MEDICAL INCRestricted Stock UnitsM Exercise/Conversion	VP-Research & Development	MExercise/Conversion	−8,837 sh	—	—	17,674
2010-03-15	ATS MEDICAL INCRestricted Stock UnitsM Exercise/Conversion	VP-Research & Development	MExercise/Conversion	−17.5K sh	—	—	52,577
2010-03-15	ATS MEDICAL INCRestricted Stock UnitsM Exercise/Conversion	VP-Research & Development	MExercise/Conversion	−13.2K sh	—	—	52,852
2010-02-16	ATS MEDICAL INCRestricted Stock UnitsA Award	VP-Research & Development	AAward	+53.4K sh	—	—	53,410
2010-02-16	ATS MEDICAL INCRestricted Stock UnitsA Award	VP-Research & Development	AAward	+15K sh	—	—	15,000
2009-09-30	ATS MEDICAL INCS Sale	VP-Research & Development	SSale	−3,770 sh	$2.72	−$10.3K	57,159.205
2009-09-29	ATS MEDICAL INCM Exercise/Conversion	VP-Research & Development	MExercise/Conversion	+10K sh	—	—	60,409.179
2009-09-29	ATS MEDICAL INCRestricted Stock UnitsM Exercise/Conversion	VP-Research & Development	MExercise/Conversion	−10K sh	—	—	20,000
2009-07-31	ATS MEDICAL INCS Sale	VP-Research & Development	SSale	−3,750 sh	$3.47	−$13K	50,409.179
2009-07-30	ATS MEDICAL INCM Exercise/Conversion	VP-Research & Development	MExercise/Conversion	+10K sh	—	—	53,696.469
2009-07-30	ATS MEDICAL INCRestricted Stock UnitsM Exercise/Conversion	VP-Research & Development	MExercise/Conversion	−10K sh	—	—	40,000
2009-03-16	ATS MEDICAL INCS Sale	VP-Research & Development	SSale	−700 sh	$2.20	−$1,540	52,750.469
2009-03-16	ATS MEDICAL INCS Sale	VP-Research & Development	SSale	−100 sh	$2.19	−$219	52,650.469
2009-03-16	ATS MEDICAL INCS Sale	VP-Research & Development	SSale	−200 sh	$2.18	−$436	52,450.469
2009-03-16	ATS MEDICAL INCS Sale	VP-Research & Development	SSale	−200 sh	$2.17	−$434	52,250.469
2009-03-16	ATS MEDICAL INCS Sale	VP-Research & Development	SSale	−8,554 sh	$2.16	−$18.5K	43,696.469
2009-03-15	ATS MEDICAL INCM Exercise/Conversion	VP-Research & Development	MExercise/Conversion	+26.4K sh	—	—	53,450.469
2009-03-15	ATS MEDICAL INCRestricted Stock UnitsM Exercise/Conversion	VP-Research & Development	MExercise/Conversion	−8,837 sh	—	—	26,511
2009-03-15	ATS MEDICAL INCRestricted Stock UnitsM Exercise/Conversion	VP-Research & Development	MExercise/Conversion	−17.5K sh	—	—	70,103
2009-02-18	ATS MEDICAL INCRestricted Stock UnitsA Award	VP-Research & Development	AAward	+66.1K sh	—	—	66,065
2008-09-30	ATS MEDICAL INCS Sale	VP-Research & Development	SSale	−3,450 sh	$2.80	−$9,663.45	26,050.549
2008-09-29	ATS MEDICAL INCM Exercise/Conversion	VP-Research & Development	MExercise/Conversion	+10K sh	—	—	29,500.549
2008-09-29	ATS MEDICAL INCRestricted Stock UnitsM Exercise/Conversion	VP-Research & Development	MExercise/Conversion	−10K sh	—	—	30,000
2007-09-29	ATS MEDICAL INCM Exercise/Conversion	VP-Research & Development	MExercise/Conversion	+10K sh	—	—	11,328.664
2007-09-29	ATS MEDICAL INCRestricted Stock UnitsM Exercise/Conversion	VP-Research & Development	MExercise/Conversion	−10K sh	—	—	40,000

Recent filings

Accepted (ET)
Aug 124
Elizondo David R0001209191-10-042226
SEC(opens sec.gov)
Jul 14
Elizondo David R0001209191-10-036442
SEC(opens sec.gov)
Mar 174
Elizondo David R0001209191-10-017619
SEC(opens sec.gov)
Feb 184
Elizondo David R0001209191-10-010516
SEC(opens sec.gov)
Sep 304
Elizondo David R0001209191-09-046204
SEC(opens sec.gov)

Companies

ATS MEDICAL INCVP-Research & Development

Address

11625 PONDVIEW COURT

CHAMPLIN, MN, 55316